These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 9419389

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of insulin on N-formyl-methionyl-leucyl-phenylalanine (fMet-Leu-Phe)-stimulated production of reactive oxygen metabolites from normal human neutrophils.
    Oldenborg PA.
    Inflamm Res; 1999 Jul; 48(7):404-11. PubMed ID: 10450791
    [Abstract] [Full Text] [Related]

  • 4. Characterization of fMet-Leu-Phe receptor-mediated Ca2+ influx across the plasma membrane of human neutrophils.
    Andersson T, Dahlgren C, Pozzan T, Stendahl O, Lew PD.
    Mol Pharmacol; 1986 Nov; 30(5):437-43. PubMed ID: 2430168
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adaptation of human neutrophil responsiveness to the chemoattractant N-formylmethionylleucylphenylalanine. Heterogeneity and/or negative cooperative interaction of receptors.
    Seligmann BE, Fletcher MP, Gallin JI.
    J Biol Chem; 1982 Jun 10; 257(11):6280-6. PubMed ID: 6281264
    [Abstract] [Full Text] [Related]

  • 10. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
    Harvath L, Yancey KB, Katz SI.
    J Immunol; 1986 Aug 15; 137(4):1305-11. PubMed ID: 3016092
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Extensive hydrolysis of N-formyl-L-methionyl-L-leucyl-L-[3H] phenylalanine by human polymorphonuclear leukocytes. A potential mechanism for modulation of the chemoattractant signal.
    Yuli I, Snyderman R.
    J Biol Chem; 1986 Apr 15; 261(11):4902-8. PubMed ID: 3957916
    [Abstract] [Full Text] [Related]

  • 15. Characteristics of binding of a potent chemotactic formyl tetrapeptide, formylmethionyl-leucyl-phenylalanyl-phenylalanine, to the receptors on rabbit neutrophils.
    Kermode JC, Muthukumaraswamy N, Freer RJ.
    J Leukoc Biol; 1988 May 15; 43(5):420-8. PubMed ID: 2836540
    [Abstract] [Full Text] [Related]

  • 16. Modulation of luminol chemiluminescence of fMet-Leu-Phe-stimulated neutrophils by affecting dephosphorylation and the metabolism of phosphatidic acid.
    Arnhold J, Benard S, Kilian U, Reichl S, Schiller J, Arnold K.
    Luminescence; 1999 May 15; 14(3):129-37. PubMed ID: 10423573
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli.
    Marasco WA, Phan SH, Krutzsch H, Showell HJ, Feltner DE, Nairn R, Becker EL, Ward PA.
    J Biol Chem; 1984 May 10; 259(9):5430-9. PubMed ID: 6371005
    [Abstract] [Full Text] [Related]

  • 19. Activation of superoxide formation and lysozyme release in human neutrophils by the synthetic lipopeptide Pam3Cys-Ser-(Lys)4. Involvement of guanine-nucleotide-binding proteins and synergism with chemotactic peptides.
    Seifert R, Schultz G, Richter-Freund M, Metzger J, Wiesmüller KH, Jung G, Bessler WG, Hauschildt S.
    Biochem J; 1990 May 01; 267(3):795-802. PubMed ID: 2160237
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.